Literature DB >> 9610874

Extent and consequences of physician delay in the diagnosis of acral melanoma.

S Metzger1, U Ellwanger, W Stroebel, U Schiebel, G Rassner, G Fierlbeck.   

Abstract

The extent and consequences of professional delay in diagnosis were analysed in 83 patients with palmoplantar and subungual melanomas treated from January 1986 to March 1997 in our department. Seventeen (52%) out of 33 subungual melanomas and 10 (20%) out of 50 palmoplantar melanomas were clinically misdiagnosed by physicians. Three palmoplantar melanomas (6%) were initially misinterpreted by pathologists. In 23 of the 27 cases (85%) the clinical misdiagnosis was made by non-dermatologists. Misdiagnosis caused a median delay of 12 months in the diagnosis of palmoplantar melanomas and 18 months in the diagnosis of subungual melanomas. Delay in diagnosis was associated with increased tumour thickness, more advanced stage at time of melanoma diagnosis and a lower estimated 5-year survival rate (15.4% versus 68.9% for palmoplantar; 68.5% versus 90.9% for subungual). Acral melanomas are frequently misdiagnosed due to their less common locations and because plantar and subungual melanomas often do not fit the 'changing mole' pattern. To Improve the patient's prognosis it is necessary to increase the physicians' skill in the diagnosis of acral melanomas. Histological examination should always be performed in acral lesions that do not heal.

Entities:  

Mesh:

Year:  1998        PMID: 9610874     DOI: 10.1097/00008390-199804000-00014

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  21 in total

1.  [Taking responsibility for one's own health. Possibilities and limits using the example of malignant melanoma].

Authors:  G Marckmann; M Möhrle; A Blum
Journal:  Hautarzt       Date:  2004-08       Impact factor: 0.751

2.  Subungual tumors.

Authors:  Timothy P Dooley; Katie E Kindt; Mark E Baratz
Journal:  Hand (N Y)       Date:  2012-09

3.  [Operative therapy of acral melanomas].

Authors:  M Möhrle; V Lichte; H Breuninger
Journal:  Hautarzt       Date:  2011-05       Impact factor: 0.751

4.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

5.  Clinical guidelines for the recognition of melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker; Katharine M Acland; Richard J Turner; Jonathan Bowling
Journal:  J Foot Ankle Res       Date:  2010-11-01       Impact factor: 2.303

6.  Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit.

Authors:  Ivan R Bristow; David Ar de Berker
Journal:  J Foot Ankle Res       Date:  2010-09-28       Impact factor: 2.303

7.  Assessment of Patient Knowledge of Longitudinal Melanonychia: A Survey Study of Patients in Outpatient Clinics.

Authors:  Pierre Halteh; Richard Scher; Amanda Artis; Shari Lipner
Journal:  Skin Appendage Disord       Date:  2016-11-09

8.  Different progression pattern between acral and nonacral melanoma: A retrospective, comparative, clinicoprognostic study of 492 cases of primary cutaneous melanoma according to tumor site.

Authors:  Joon Min Jung; Chang Jin Jung; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Woo Jin Lee
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 [SEASON]       Impact factor: 2.545

9.  A rare form of melanoma masquerading as a diabetic foot ulcer: a case report.

Authors:  Susan Thomas; Yuan-Xiang Meng; Vijaykumar G Patel; Gregory Strayhorn
Journal:  Case Rep Endocrinol       Date:  2012-04-04

10.  Acral Lentiginous Melanoma Developing during Long-standing Atypical Melanosis: Usefulness of Dermoscopy for Detection of Early Acral Melanoma.

Authors:  Tae Seok Oh; Eui Jong Bae; Ki Woong Ro; Soo Hong Seo; Sang Wook Son; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.